Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 2
2005 2
2006 3
2007 1
2008 6
2009 3
2010 4
2011 3
2012 1
2013 3
2014 9
2015 11
2016 15
2017 11
2018 4
2019 3
2020 3
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV. Trauner M, et al. Among authors: eksteen b. Hepatology. 2019 Sep;70(3):788-801. doi: 10.1002/hep.30509. Epub 2019 Mar 10. Hepatology. 2019. PMID: 30661255 Free PMC article. Clinical Trial.
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM; International PSC Study Group. Weismüller TJ, et al. Among authors: eksteen b. Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6. Gastroenterology. 2017. PMID: 28274849 Free PMC article.
Retraction notice to: PS124-Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199].
Eksteen B, Heatherington J, Oshiomogo J, Panaccione R, Kaplan G, Ghosh S. Eksteen B, et al. J Hepatol. 2017 Jan;66(1):254. doi: 10.1016/j.jhep.2016.10.020. Epub 2016 Dec 15. J Hepatol. 2017. PMID: 28042931 No abstract available.
Infections and the liver.
Eksteen B. Eksteen B. Dig Dis. 2011;29(2):184-90. doi: 10.1159/000323884. Epub 2011 Jul 5. Dig Dis. 2011. PMID: 21734383 Review.
Immune-mediated liver injury.
Eksteen B, Afford SC, Wigmore SJ, Holt AP, Adams DH. Eksteen B, et al. Semin Liver Dis. 2007 Nov;27(4):351-66. doi: 10.1055/s-2007-991512. Semin Liver Dis. 2007. PMID: 17979072 Review.
Gastroenterology.
Jankowski J, de Caestecker J, Eksteen B, Perry I. Jankowski J, et al. Among authors: eksteen b. BMJ. 2002 Oct 12;325(7368):S113. doi: 10.1136/bmj.325.7368.s113a. BMJ. 2002. PMID: 12376456 No abstract available.
Predicting risk in primary biliary cholangitis.
Eksteen B. Eksteen B. Hepatology. 2016 Mar;63(3):697-9. doi: 10.1002/hep.28377. Epub 2016 Jan 14. Hepatology. 2016. PMID: 26638198 No abstract available.
Characterization of animal models for primary sclerosing cholangitis (PSC).
Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, Keitel V, Schramm C, Marschall HU, Karlsen TH, Melum E, Kaser A, Eksteen B, Strazzabosco M, Manns M, Trauner M; International PSC Study Group (IPSCSG). Fickert P, et al. Among authors: eksteen b. J Hepatol. 2014 Jun;60(6):1290-303. doi: 10.1016/j.jhep.2014.02.006. Epub 2014 Feb 19. J Hepatol. 2014. PMID: 24560657 Free PMC article. Review.
77 results